These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38767640)

  • 1. Proteomics analysis of coronary atherosclerotic heart disease with different Traditional Chinese Medicine syndrome types before and after percutaneous coronary intervention.
    Zhibo W; Ying LI; Daoping W; Bo MA; Lan M; Junguo R; Jinghua L; Jianxun L
    J Tradit Chin Med; 2024 Jun; 44(3):554-563. PubMed ID: 38767640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis on outcome of 5284 patients with coronary artery disease: the role of integrative medicine.
    Gao ZY; Xu H; Shi DZ; Wen C; Liu BY
    J Ethnopharmacol; 2012 Jun; 141(2):578-83. PubMed ID: 21924336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the "gene-protein-metabolite" network of coronary heart disease with phlegm and blood stasis syndrome by integrated multi-omics strategy.
    Yang G; Zhou S; He H; Shen Z; Liu Y; Hu J; Wang J
    Front Pharmacol; 2022; 13():1022627. PubMed ID: 36523490
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study on changes of TCM syndrome in patients with coronary heart disease before and after intervention treatment].
    Chen BJ; Pan ZQ; Su XX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Aug; 27(8):689-91. PubMed ID: 17879529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expert survey for Chinese medicine syndrome characteristics of different clinical types of coronary artery disease based on the Delphi method].
    Bi YF; Mao JY; Wang XL; Li B; Hou YZ; Zhao ZQ; Ge YB; Zhao GF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1192-6. PubMed ID: 25509260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation Analysis between Traditional Chinese Medicine Syndromes and Gastrointestinal Bleeding after Percutaneous Coronary Intervention.
    Zhang C; Huang C; Wang M; Kong X; Liu G; Wang J
    Evid Based Complement Alternat Med; 2018; 2018():7356546. PubMed ID: 29955236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Impact of Cholesterol Absorption Marker on New Atherosclerotic Lesion Progression After Coronary Intervention During Statin Therapy.
    Mori K; Ishida T; Tsuda S; Oshita T; Shinohara M; Hara T; Irino Y; Toh R; Hirata KI
    J Atheroscler Thromb; 2017 Feb; 24(2):123-132. PubMed ID: 27487947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of Tongguan capsule on post-intervention patients of coronary heart disease with qi-deficiency and blood stasis syndrome].
    Li J; Zhang MZ; Chen BJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Jan; 28(1):32-5. PubMed ID: 18418966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline white blood cell count-to-apolipoprotein A1 ratio as a novel predictor of long-term adverse outcomes in patients who underwent percutaneous coronary intervention: a retrospective cohort study.
    Pan Y; Zhang J; Wu TT; Hou XG; Yang Y; Ma X; Ma YT; Zheng YY; Xie X
    Lipids Health Dis; 2020 Mar; 19(1):43. PubMed ID: 32178685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of Chinese herbs for supplementing qi, nourishing yin and activating blood circulation on heart function of patients with acute coronary syndrome after percutaneous coronary intervention.
    Liu HY; Wang W; Shi DZ; Ge JB; Zhang L; Peng J; Wang CL; Wang PL
    Chin J Integr Med; 2012 Jun; 18(6):423-30. PubMed ID: 22382523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary metabolomic profiling reveals difference between two traditional Chinese medicine subtypes of coronary heart disease.
    Guo N; Chen Y; Yang X; Yan H; Fan B; Quan J; Wang M; Yang H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122808. PubMed ID: 34218095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics and Risk Factors of Periprocedural Myocardial Injury in Patients with Elective PCI in a TCM Hospital.
    Li X; Zhang HY; Shang JJ; Liu HX; Zhou Q; Lai XL
    Evid Based Complement Alternat Med; 2022; 2022():7158740. PubMed ID: 35368758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retrospective cross-sectional survey of clinical characteristics and syndrome elements distribution at different stages of coronary heart disease].
    Zhong SJ; Zhao XY; Gao X; Huang RY; Chen J; Wu H; Fang HC; Xian SX
    Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1406-1414. PubMed ID: 38621989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical analysis of acute coronary syndrome patients with Qi-blood syndromes: establishment of a diagnostic prediction model for syndrome differentiation.
    Zhao Y; Peng H; Wang S; Liu J
    Ann Palliat Med; 2020 Jul; 9(4):2096-2110. PubMed ID: 32692227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the mechanism of TCM formulae in the treatment of different types of coronary heart disease by network pharmacology and machining learning.
    Yang J; Tian S; Zhao J; Zhang W
    Pharmacol Res; 2020 Sep; 159():105034. PubMed ID: 32565312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass-spectrometric analysis of APOB polymorphism rs1042031 (G/T) and its influence on serum proteome of coronary artery disease patients: genetic-derived proteomics consequences.
    Zafar M; Malik IR; Mirza MR; Awan FR; Nawrocki A; Hussain M; Khan HN; Abbas S; Choudhary MI; Larsen MR
    Mol Cell Biochem; 2024 Jun; 479(6):1349-1361. PubMed ID: 37410210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical comprehensive evaluation of Naoxintong Capsules in treatment of cerebral infarction with Qi deficiency and blood stasis syndrome and coronary heart disease angina pectoris].
    Geng HJ; Xie YM; Wang ZF
    Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6087-6095. PubMed ID: 34951236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research status of pathogenesis of anxiety or depression after percutaneous coronary intervention and Traditional Chinese Medicine intervention.
    Ning B; Ge T; Zhao QQ; Feng LS; Wu YQ; Chen H; Lian K; Zhao MJ
    J Ethnopharmacol; 2024 Jun; 327():118017. PubMed ID: 38462028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alkaline phosphatase-to-albumin ratio as a novel predictor of long-term adverse outcomes in coronary artery disease patients who underwent PCI.
    Dai XY; Zheng YY; Tang JN; Wang W; Guo QQ; Yin SS; Zhang JC; Cheng MD; Song FH; Liu ZY; Wang K; Jiang LZ; Fan L; Yue XT; Bai Y; Zhang ZL; Zheng RJ; Zhang JY
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34121126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative Association of Circulating MicroRNA-126 with High-sensitive C-reactive Protein and Vascular Cell Adhesion Molecule-1 in Patients with Coronary Artery Disease Following Percutaneous Coronary Intervention.
    Wang JN; Yan YY; Guo ZY; Jiang YJ; Liu LL; Liu B
    Chin Med J (Engl); 2016 Dec; 129(23):2786-2791. PubMed ID: 27900989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.